Dr. Andrew Anzalone, Head of the Prime Editing Platform and Scientific Co-Founder of Prime Medicine joins Cell & Gene: The Podcast to talk with Host Erin Harris about prime editing - what it is and why it is a major technological advancement in gene editing. Anzalone explains why prime editing has a broad applicability for different tissue and cell types to be used in different therapeutic applications.

#celltherapy #genetherapy

https://www.thermofisher.com/us/en/ho...

Audio version available here: https://www.cellandgene.com/doc/insid...

Subscribe to the podcast:

Apple - https://podcasts.apple.com/us/podcast...
Spotify - https://open.spotify.com/show/78NSjRu...
Google - https://podcasts.google.com/feed/aHR0...